Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology
May 21, 2026Sygnature Discovery, Vivo Pharmacology
Sygnature Discovery, an integrated drug discovery contract research organisation (CRO), has announced the appointment of Susanne Back as Head of …
NICE recommends sotatercept for pulmonary arterial hypertension
May 20, 2026NICE, Winrevair, pulmonary arterial hypertension, sotatercept
The National Institute for Health and Care Excellence (NICE) has recommended Winrevair (sotatercept) as a treatment option for adults with …
Vetter begins construction of new injectable medicines facility
May 20, 2026Manufacturing and Production Vetter
Vetter, a contract development and manufacturing organisation (CDMO), has begun construction of a new pharmaceutical manufacturing site in Saarlouis, Germany, …
Study explores genomic testing approach for unexplained infertility
May 14, 2026Research and Development infertility
Researchers across the Asia Pacific region have reported findings from a study investigating whether long-read whole genome sequencing could improve …
Celtic Renewables receives £7m to develop bio-based solvents
May 14, 2026Manufacturing and Production Celtic Renewables
Scottish green chemicals company Celtic Renewables is part of a consortium that has secured £7m in funding to support development …
Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care
May 13, 2026Research and Development Sophia Genetics, Synnovis
Synnovis and SOPHiA GENETICS have announced a collaboration to expand blood-based cancer testing for patients with lung and breast cancer …
MHRA to establish Northern Ireland hub for life sciences sector
May 13, 2026MHRA
The Medicines and Healthcare products Regulatory Agency (MHRA) is establishing a new hub in Northern Ireland aimed at strengthening engagement …
Shilpa Medicare signs manufacturing deal with NXI Therapeutics
May 12, 2026Manufacturing and Production Shilpa Medicare
Shilpa Medicare has entered into a long-term development and manufacturing agreement with Swiss biotech company NXI Therapeutics focused on an …
CGT Catapult backs AI platform for gene therapy delivery
May 12, 2026Cell and Gene Therapy Catapult
Cell and Gene Therapy Catapult (CGT Catapult) is providing investment to UK biotech company Lir Therapeutics to support development of …
Campaign highlights low expectations among patients with depression
May 7, 2026Johnson & Johnson, major depressive disorder (MDD)
A new global awareness campaign from Johnson & Johnson is aiming to encourage people with major depressive disorder (MDD) to …
Practical AI toolkit launched to help manufacturers cut through complexity
May 6, 2026Manufacturing and Production AI, Made Smarter
A new guide from Made Smarter is helping manufacturers cut through the noise around AI and focus on what actually …
Syngene appoints Maninder Kapoor Puri as CHRO
May 6, 2026Research and Development Syngene International
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Maninder Kapoor Puri as …
BioPhorum acquires PharmaX Solutions
May 5, 2026Manufacturing and Production BioPhorum, PharmaX Solutions
BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions across pharmaceutical manufacturing and …
Syngene appoints Abhijit Zutshi as CCO
May 5, 2026Research and Development Syngene International
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Abhijit Zutshi as Chief …
Japanese pharma outsources earlier as peptide development challenges grow
April 29, 2026Peptide therapies, peptide
Japanese pharmaceutical companies are increasingly engaging contract development and manufacturing organisations (CDMOs) earlier in the drug development process, as the …
Study suggests phospholipid therapy may impact fatty liver disease outcomes
April 29, 2026Research and Development fatty liver disease, phospholipid therapy
A randomised clinical trial has reported that treatment with essential phospholipids (Essentiale) may reduce liver fat and improve symptoms in …
FDA signals support for development of psychedelic therapies in mental healthmental health
April 28, 2026Neurology, mental health
The US Food and Drug Administration (FDA) has announced a series of measures aimed at supporting the development of psychedelic-based …
New web series explores path from ophthalmic research to patient access
April 28, 2026Research and Development Opthalmology
A new YouTube web series has been launched to examine how ophthalmic innovations progress from early research through to approved …
EMA backs plozasiran for rare lipid disorder with high pancreatitis risk
April 27, 2026Research and Development The European Medicines Agency (EMA), plozasiran
The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Redemplo (plozasiran) to treat adults with familial chylomicronaemia …
Study explores speech as marker in rare neurodegenerative disease
April 27, 2026Research and Development SynaptixBio, neurodegenerative disease
SynaptixBio has highlighted the potential of speech analysis as a non-invasive way to track disease progression in neurodegenerative conditions, as …
